2 In 2024, the approved commercial versions of semaglutide are Ozempic 3-4 , Rybelsus 3,5 , and Wegovy injection 3,6 , developed by Novo Nordisk
Frequently Asked Questions International shipping: 714 days
By activating the GLP-1 receptor, GLP-1RA enhances insulin secretion and inhibits glucagon secretion to lower blood glucose, ingeniously suppressing appetite, increasing satiety, and delaying gastric emptying, thus achieving weight reduction (Torekov et al., 2011
Take the next step toward healthier, more sustainable weight management
Some of these studies find that semaglutide is unlikely to be cost-effective [54, 55], while others reported support for the likely cost-effectiveness of semaglutide [56]
Safety & Considerations Administered by qualified dermatologists in a sterile clinical environment Regular monitoring ensures maximum safety and optimal outcomes Not recommended for pregnant women or patients with certain health conditions Real Stories, Real Results Listen to our Patients share their journey and see how personalized care and advanced treatments made all the difference